News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
313 Results
Type
Article (15)
Press Release (298)
Section
Business (66)
Deals (12)
Drug Development (92)
FDA (13)
Job Trends (41)
News (172)
Policy (17)
Tag
Alliances (15)
Approvals (12)
Best Places to Work (40)
Brain cancer (1)
Cancer (7)
Clinical research (70)
Collaboration (1)
COVID-19 (5)
Data (9)
Diagnostics (5)
Earnings (33)
Events (76)
FDA (14)
Funding (1)
Government (6)
Healthcare (6)
Infectious disease (5)
Intellectual property (2)
IPO (11)
Job creations (1)
Liver cancer (1)
Medical device (3)
Medtech (3)
Mergers & acquisitions (1)
NextGen: Class of 2025 (6)
Non-profit (1)
Pancreatic cancer (3)
Patents (4)
Patient recruitment (1)
People (16)
Phase I (49)
Phase II (39)
Phase III (18)
Pipeline (5)
Preclinical (19)
Real estate (1)
Regulatory (15)
Research institute (4)
Startups (1)
Vaccines (2)
Date
Last 7 days (3)
Last 30 days (4)
Last 365 days (32)
2025 (32)
2024 (23)
2023 (34)
2022 (42)
2021 (31)
2020 (71)
2019 (33)
2018 (10)
2017 (22)
2016 (14)
2013 (1)
Location
Asia (1)
Canada (1)
Europe (3)
Texas (33)
United States (33)
313 Results for "moleculin".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Moleculin Announces New Annamycin Collaboration in Brain Tumors
December 8, 2025
·
6 min read
Press Releases
Moleculin to Participate in the Virtual Investor Closing Bell Series
November 27, 2025
·
2 min read
Press Releases
Moleculin Announces Exercise of Warrants for $6.8 Million Gross Proceeds
December 11, 2025
·
5 min read
Press Releases
Moleculin Expands Global IP Portfolio with New Australian Patent for Annamycin
October 30, 2025
·
5 min read
Press Releases
Moleculin Announces Completion of Treatment for the 45 Patients in Pivotal “MIRACLE” Phase 3 AML Trial on Pace for Q1 2026
December 10, 2025
·
7 min read
Press Releases
Moleculin Reports 60% of First 45 Subjects in Pivotal “MIRACLE” Phase 3 AML Trial Consented
November 14, 2025
·
6 min read
Press Releases
Moleculin Announces Grant Funded Research Evaluating Annamycin for the Treatment of Pancreatic Cancer at UNC-Chapel Hill
November 13, 2025
·
6 min read
Press Releases
Moleculin Announces New Investigator-Initiated Study of Annamycin for Treating Pancreatic Cancer
October 24, 2025
·
8 min read
Press Releases
Moleculin Announces Notice of Allowance for Canadian Patent Covering Annamycin
September 26, 2025
·
5 min read
Press Releases
Moleculin Issues New Positive AML Overall Survival Data:
August 28, 2025
·
9 min read
1 of 32
Next
